Pre-made Pexelizumab benchmark antibody (scFv, anti-C5/CO5 therapeutic antibody, Anti-CPAMD4/ECLZB Antibody) for drug discovery and mechanism of action (MOA) research

Pre-made Pexelizumab benchmark antibody (scFv, anti-C5/CO5 therapeutic antibody, Anti-CPAMD4/ECLZB Antibody) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Pexelizumab is a drug designed to reduce side effects of coronary artery bypass grafting[1] and angioplasty,[2][3] among other types of cardiac surgery. It is a single chain variable fragment of a monoclonal antibody targeted against component 5 of the complement system.[4]

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-INN-959-1mg	1mg	3090
GMP-Bios-INN-959-10mg	10mg	Inquiry
GMP-Bios-INN-959-100mg	100mg	Inquiry
GMP-Bios-INN-959-xmg	≥100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Products Name (INN Index)	Pre-Made Pexelizumab Biosimilar, Scfv, Anti-C5/CO5 Antibody: Anti-CPAMD4/ECLZB therapeutic antibody
INN Name	Pexelizumab
Target	C5/CO5
Format	scFv
Derivation	Humanized
Species Reactivity	human
CH1 Isotype	scFv - nd - nd
VD LC	scFv - nd - nd
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
Companies	Alexion Pharmaceuticals Inc. (New Haven CT USA)
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech	0